The Influence of Kidney Function on Dapagliflozin Exposure, Metabolism and Pharmacodynamics in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus

British Journal of Clinical Pharmacology - United Kingdom
doi 10.1111/bcp.12056
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Practice of Dapagliflozin Application in Patients With Type 2 Diabetes Mellitus

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY
2015English

The Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus

Journal of Clinical Pharmacology
Pharmacology
2017English

Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients With Type 2 Diabetes Mellitus

Advances in Therapy
MedicinePharmacology
2015English

Dapagliflozin: Cardiovascular Safety and Benefits in Type 2 Diabetes Mellitus

Cureus
2017English

Pharmacokinetics and Pharmacodynamics of Dapagliflozin in Combination With Insulin in Japanese Patients With Type 1 Diabetes

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Topiramate Improves Neurovascular Function, Epidermal Nerve Fiber Morphology, and Metabolism in Patients With Type 2 Diabetes Mellitus

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2010English

Evaluating the Excretory Function of Solitary Kidney in Patients With Urolithiasis on a Background of Type 2 Diabetes Mellitus

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY
2018English

Dapagliflozin: A New Adjunct in the Treatment of Type 2 Diabetes Mellitus

International Journal of Basic & Clinical Pharmacology
2014English

Cystatin C Study in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Medical News of North Caucasus
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy